BiomX Inc. received a notice from NYSE American on March 25, 2026, indicating non-compliance with continued listing standards. The non-compliance stems from failing to meet minimum stockholders' equity requirements: less than $2.0 million (losses in 2 of 3 recent fiscal years), less than $4.0 million (losses in 3 of 4 recent fiscal years), and less than $6.0 million (losses in 5 recent fiscal years). The company is not eligible for any exemptions, including the one for market capitalization exceeding $50 million. BiomX must submit a compliance plan to NYSE American by April 24, 2026, outlining actions to regain compliance by September 25, 2027. Failure to submit an acceptable plan or meet the compliance deadline will result in delisting proceedings. The company also disclosed a going concern qualification in its audit opinion for the fiscal year ended December 31, 2025, as previously reported in its Form 10-K filed February 19, 2026. The notice has no immediate effect on the trading of BiomX common stock (PHGE) on NYSE American.